A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells. Seung E, Xing Z, Wu L, Rao E, et al. Nature 2022 Feb 23. pii: 10.1038/s41586-022-04439.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Seung E, Xing Z, Wu L, Rao E, et al. A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells. Nature 2022 Feb 23. pii: 10.1038/s41586-022-04439.
PMID: 35197632